Company registration number 10884897 (England and Wales)
THINKMORE HEALTHCARE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025
PAGES FOR FILING WITH REGISTRAR
THINKMORE HEALTHCARE LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 7
THINKMORE HEALTHCARE LIMITED
BALANCE SHEET
AS AT 31 OCTOBER 2025
31 October 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
-
0
-
0
Tangible assets
3
980,753
990,761
Investments
4
2,535,215
2,535,215
3,515,968
3,525,976
Current assets
Debtors
5
2,101,243
1,443,957
Cash at bank and in hand
22,921
380,626
2,124,164
1,824,583
Creditors: amounts falling due within one year
6
(2,100,903)
(2,351,751)
Net current assets/(liabilities)
23,261
(527,168)
Total assets less current liabilities
3,539,229
2,998,808
Creditors: amounts falling due after more than one year
7
(1,557,362)
(1,177,177)
Net assets
1,981,867
1,821,631
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
1,981,767
1,821,531
Total equity
1,981,867
1,821,631
THINKMORE HEALTHCARE LIMITED
BALANCE SHEET (CONTINUED)
AS AT 31 OCTOBER 2025
31 October 2025
- 2 -

For the financial year ended 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 15 July 2026 and are signed on its behalf by:
Mr SK Patel
Director
Company registration number 10884897 (England and Wales)
THINKMORE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025
- 3 -
1
Accounting policies
Company information

Thinkmore Healthcare Limited is a private company limited by shares incorporated in England and Wales. The registered office is Elthorne Gate, 64 High Street, Pinner, Middlesex, HA5 5QA.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group.

1.2
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold land and buildings
1% on straight line method

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Fixed asset investments

Investments in subsidiary undertakings are recognised at cost.

1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

THINKMORE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
1
Accounting policies
(Continued)
- 4 -

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.6
Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current tax

Current or deferred taxation assets and liabilities are not discounted.

 

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

 

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

 

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

THINKMORE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
1
Accounting policies
(Continued)
- 5 -
1.7

Related party exemption

The company has taken advantage of the exemption, under the terms of Financial Reporting Standard 102,' The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
2
3
Tangible fixed assets
Land and buildings
£
Cost
At 1 November 2024 and 31 October 2025
1,000,769
Depreciation and impairment
At 1 November 2024
10,008
Depreciation charged in the year
10,008
At 31 October 2025
20,016
Carrying amount
At 31 October 2025
980,753
At 31 October 2024
990,761
4
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
2,535,215
2,535,215
THINKMORE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
- 6 -
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Amounts owed by group undertakings
1,311,431
920,000
Other debtors
789,812
523,957
2,101,243
1,443,957
6
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
72,637
82,505
Trade creditors
14
23
Amounts owed to group undertakings
1,614,292
1,736,224
Other creditors
413,960
532,999
2,100,903
2,351,751
7
Creditors: amounts falling due after more than one year
2025
2024
Notes
£
£
Bank loans and overdrafts
1,557,362
1,177,177
Creditors which fall due after five years are payable as follows:
Payable by instalments
1,266,813
-
THINKMORE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
7
Creditors: amounts falling due after more than one year
(Continued)
- 7 -

The bank loan falling due less than 1 year and after 1 year are secured by charges over the following:-

 

1. An omnibus guarantee and set off agreement (OGSA) among the Bank and Thinkmore Healthcare Limited, AJM Mansell Limited, AJM Mansell Holdings Limited, P.Rincemount (Trading) Ltd and P.Rincemount Trading (Holdings) Ltd

together with such other security as the Bank may from time to time hold in respect of the debts and liabilities of any guarantor to the Bank.

 

2. A first legal charge from A.J.M. Mansell Limited over the leasehold land and buildings at 8 St Johns Parade, Mattock Lane, London, W13 9LL.

 

3. A first legal charge dated 06/12/2021 from , P.Rincemount (Trading) Ltd over the leasehold land and buildings Ground and Basement Floors, 4 Castle Hill Parade, The Avenue, London, W13 8JP.

 

4. An all moneys joint and several guarantee dated 04/09/2017 from Sanjay Patel & Rajan Shah for a principal amount of £325,000 plus interest and other costs as detailed in the guarantee together with such other security as the Bank may from time to time hold in respect of the debts and liabilities of the guarantors to the Bank.

 

5. Debentures from Thinkmore Healthcare Limited dated 01/11/2017, AJM Mansell Limited dated 01/11/2017, AJM Mansell Holdings Limited dated 01/11/2017, P.Rincemount (Trading) Ltd dated 06/12/2021 and P.Rincemount Trading (Holdings) Ltd dated 06/12/2021.

8
Related party transactions

The following amounts were outstanding at the reporting end date:

2025
2024
Amounts due to related parties
£
£
Entities with control, joint control or significant influence over the company
265,000
265,000

Included in the other creditors is the above amount owed from related entities with common directors and shareholders. The outstanding balance is unsecured, interest free and repayable on demand.

 

2025
2024
Amounts due from related parties
£
£
Entities with control, joint control or significant influence over the company
784,483
503,204

Included in the other debtors is the above amount owed from related entities with common directors and shareholders. The outstanding balance is unsecured, interest free and repayable on demand.

2025-10-312024-11-01falsefalsefalse15 July 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityMr SK PatelMr RM Shah108848972024-11-012025-10-31108848972025-10-31108848972024-10-3110884897core:LandBuildings2025-10-3110884897core:LandBuildings2024-10-3110884897core:CurrentFinancialInstrumentscore:WithinOneYear2025-10-3110884897core:CurrentFinancialInstrumentscore:WithinOneYear2024-10-3110884897core:Non-currentFinancialInstrumentscore:AfterOneYear2025-10-3110884897core:Non-currentFinancialInstrumentscore:AfterOneYear2024-10-3110884897core:CurrentFinancialInstruments2025-10-3110884897core:CurrentFinancialInstruments2024-10-3110884897core:ShareCapital2025-10-3110884897core:ShareCapital2024-10-3110884897core:RetainedEarningsAccumulatedLosses2025-10-3110884897core:RetainedEarningsAccumulatedLosses2024-10-3110884897bus:Director12024-11-012025-10-3110884897core:LandBuildingscore:LongLeaseholdAssets2024-11-012025-10-31108848972023-11-012024-10-3110884897core:LandBuildings2024-10-3110884897core:LandBuildings2024-11-012025-10-3110884897core:Non-currentFinancialInstruments2025-10-3110884897core:Non-currentFinancialInstruments2024-10-3110884897core:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity2025-10-3110884897bus:PrivateLimitedCompanyLtd2024-11-012025-10-3110884897bus:SmallCompaniesRegimeForAccounts2024-11-012025-10-3110884897bus:FRS1022024-11-012025-10-3110884897bus:AuditExemptWithAccountantsReport2024-11-012025-10-3110884897bus:Director22024-11-012025-10-3110884897bus:FullAccounts2024-11-012025-10-31xbrli:purexbrli:sharesiso4217:GBP